Rilinger, Jonathan http://orcid.org/0000-0001-9333-3629
Kern, Winfried V.
Duerschmied, Daniel
Supady, Alexander
Bode, Christoph
Staudacher, Dawid L.
Wengenmayer, Tobias
Article History
Received: 20 May 2020
Accepted: 23 May 2020
First Online: 3 June 2020
Ethics approval and consent to participate
: Ethics committee of the Albert-Ludwigs-University Freiburg, GermanyEthical approval number: 203/20 (FF/MC), date of approval: 21.04.2020.We certify that this trial has received ethical approval from the appropriate ethical committee as described above.Written informed consent will be obtained from the patient or legal authorized representative.If patients are unable to consent because of a severe COVID-19 pneumonia and an official legal representative was not declared so far, patients can be enrolled when a participation conforms to the presumed will of the patient, according to international guidelines and local laws (ยง 41 (1) sentence 2 and sentence 3 AMG).
: Not applicable.
: The authors declare that they have no competing interests.